LEMAITRE VASCULAR INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $249.6M | $219.9M | $193.5M | $161.7M | $154.4M |
| Cost of revenue | $71.1M | $69.0M | $66.4M | $56.8M | $53.0M |
| Gross profit | $178.5M | $150.9M | $127.0M | $104.9M | $101.4M |
| Research and development | $14.1M | $15.7M | $17.0M | $13.3M | $11.8M |
| Operating expenses | $110.6M | $98.6M | $90.3M | $78.1M | $65.0M |
| Operating income | $67.9M | $52.3M | $36.7M | $26.8M | $36.4M |
| Interest expense | $5.2M | $205,000 | $0 | $0 | $2.2M |
| Pretax income | $75.2M | $56.9M | $39.5M | $27.5M | $34.3M |
| Income tax expense | $17.4M | $12.8M | $9.4M | $6.9M | $7.4M |
| Net income | $57.7M | $44.0M | $30.1M | $20.6M | $26.9M |
| Balance Sheet | |||||
| Cash and equivalents | $28.2M | $25.6M | $24.3M | $19.1M | $13.9M |
| Current assets | $468.2M | $402.2M | $194.6M | $161.7M | $139.9M |
| Total assets | $615.7M | $551.8M | $346.8M | $310.5M | $292.8M |
| Current liabilities | $36.3M | $30.6M | $29.9M | $25.3M | $21.8M |
| Total liabilities | $222.2M | $214.5M | $48.9M | $42.3M | $38.7M |
| Stockholders' equity | $393.5M | $337.3M | $297.9M | $268.2M | $254.2M |
| Cash Flow Statement | |||||
| Cash from operations | $81.3M | $44.1M | $36.8M | $25.4M | $35.1M |
| Depreciation and amortization | $10.4M | $9.6M | $9.5M | $9.4M | $11.1M |
| Stock-based compensation | $7.8M | $6.6M | $5.3M | $4.2M | $3.5M |
| Capital expenditure | $6.8M | $7.0M | $7.3M | $3.2M | $4.9M |
| Free cash flow | $74.5M | $37.2M | $29.5M | $22.1M | $30.2M |
| Dividends paid | $18.1M | $14.4M | $12.4M | $11.0M | $9.3M |
| Share repurchases | $1.8M | $1.7M | $853,000 | $642,000 | $802,000 |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 22.9M · Free float 92.6%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.